Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Long-Term Investments (2021 - 2023)

Bioregenx's Long-Term Investments history spans 3 years, with the latest figure at $100.0 for Q4 2023.

  • Quarterly results put Long-Term Investments at $100.0 for Q4 2023, down 99.52% from a year ago — trailing twelve months through Dec 2023 was $100.0 (down 99.52% YoY), and the annual figure for FY2023 was $100.0, down 99.52%.
  • Long-Term Investments for Q4 2023 was $100.0 at Bioregenx, down from $200.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $60000.0 in Q4 2021 to a low of $100.0 in Q4 2023.
  • The 3-year median for Long-Term Investments is $31500.0 (2022), against an average of $29050.0.
  • The sharpest move saw Long-Term Investments plummeted 65.0% in 2022, then plummeted 99.52% in 2023.
  • Year by year, Long-Term Investments stood at $60000.0 in 2021, then plummeted by 65.0% to $21000.0 in 2022, then plummeted by 99.52% to $100.0 in 2023.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $100.0, $200.0, and $51000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.